Raras
Buscar doenças, sintomas, genes...
Acondroplasia
ORPHA:15CID-10 · Q77.4CID-11 · LD24.00OMIM 100800DOENÇA RARA

A Acondroplasia é a forma mais comum de condrodisplasia, uma condição que afeta o crescimento da cartilagem. Ela se caracteriza por: braços e pernas mais curtos (principalmente na parte superior, perto do tronco), uma curvatura acentuada na parte inferior da coluna (lordose), dedos curtos nas mãos e nos pés, e uma cabeça grande, com a testa mais saliente e a parte central do rosto menos desenvolvida.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A Acondroplasia é a forma mais comum de condrodisplasia, uma condição que afeta o crescimento da cartilagem. Ela se caracteriza por: braços e pernas mais curtos (principalmente na parte superior, perto do tronco), uma curvatura acentuada na parte inferior da coluna (lordose), dedos curtos nas mãos e nos pés, e uma cabeça grande, com a testa mais saliente e a parte central do rosto menos desenvolvida.

Pesquisas ativas
19 ensaios
47 total registrados no ClinicalTrials.gov
Publicações científicas
2.354 artigos
Último publicado: 2026 Apr 10
Medicamentos
2 registrados
VOSORITIDE, INFIGRATINIB

Tem tratamento?

2 medicamentos registrados
Ver detalhes, fases e interações →
VOSORITIDEINFIGRATINIB

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
Antenatal
+ neonatal
🏥
SUS: Cobertura mínimaScore: 35%
1 medicamentos CEAFCentros em: PA, PR, SC, RS, ES +10CID-10: Q77.4
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (5)
0202010503
Cariótipo — bandas G, Q ou Rgenetic_test
0202010600
Pesquisa de microdeleções/microduplicações por FISHlab_test
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202010260
Dosagem de alfa-fetoproteína
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🦴
Ossos e articulações
22 sintomas
🫁
Pulmão
5 sintomas
😀
Face
5 sintomas
👂
Ouvidos
3 sintomas
🧠
Neurológico
3 sintomas
🫃
Digestivo
3 sintomas

+ 31 sintomas em outras categorias

Características mais comuns

100%prev.
Hipoplasia pulmonar
Obrigatório (100%)
100%prev.
HP:0003577
Obrigatório (100%)
100%prev.
Morte na infância
Obrigatório (100%)
100%prev.
Polidrâmnio
Obrigatório (100%)
100%prev.
Encurvamento ulnar
Obrigatório (100%)
100%prev.
Platispondilia grave
Obrigatório (100%)
74sintomas
Muito frequente (30)
Frequente (19)
Ocasional (7)
Sem dados (18)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 74 características clínicas mais associadas, ordenadas por frequência.

Hipoplasia pulmonarPulmonary hypoplasia
Obrigatório (100%)100%
HP:0003577
Obrigatório (100%)100%
Morte na infânciaDeath in infancy
Obrigatório (100%)100%
PolidrâmnioPolyhydramnios
Obrigatório (100%)100%
Encurvamento ulnarUlnar bowing
Obrigatório (100%)100%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico2.354PubMed
Últimos 10 anos200publicações
Pico2025131 papers
Linha do tempo
2026Hoje · 2026🧪 1996Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: Autosomal dominant.

FGFR3Fibroblast growth factor receptor 3Disease-causing germline mutation(s) (gain of function) inAltamente restrito
FUNÇÃO

Tyrosine-protein kinase that acts as a cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell proliferation, differentiation and apoptosis. Plays an essential role in the regulation of chondrocyte differentiation, proliferation and apoptosis, and is required for normal skeleton development. Regulates both osteogenesis and postnatal bone mineralization by osteoblasts. Promotes apoptosis in chondrocytes, but can also promote cancer cell proliferat

LOCALIZAÇÃO

Cell membraneCytoplasmic vesicleEndoplasmic reticulumSecreted

VIAS BIOLÓGICAS (2)
Signaling by FGFR3 in diseaset(4;14) translocations of FGFR3
MECANISMO DE DOENÇA

Achondroplasia

A frequent form of short-limb dwarfism. It is characterized by a long, narrow trunk, short extremities, particularly in the proximal (rhizomelic) segments, a large head with frontal bossing, hypoplasia of the midface and a trident configuration of the hands. ACH is an autosomal dominant disease.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Not Sun Exposed Suprapubic
364.6 TPM
Skin Sun Exposed Lower leg
356.5 TPM
Esôfago - Mucosa
199.7 TPM
Brain Caudate basal ganglia
148.4 TPM
Brain Nucleus accumbens basal ganglia
135.4 TPM
OUTRAS DOENÇAS (19)
nevus, epidermalsevere achondroplasia-developmental delay-acanthosis nigricans syndromelacrimoauriculodentodigital syndrome 2testicular germ cell tumor
HGNC:3690UniProt:P22607

Medicamentos e terapias

VOSORITIDEPhase 4

Mecanismo: Atrial natriuretic peptide receptor B binding agent

INFIGRATINIBPhase 2

Mecanismo: Fibroblast growth factor receptor inhibitor

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

416 variantes patogênicas registradas no ClinVar.

🧬 FGFR3: GRCh38/hg38 4p16.3-15.33(chr4:68454-12774004)x1 ()
🧬 FGFR3: GRCh38/hg38 4p16.3(chr4:68454-4013853)x3 ()
🧬 FGFR3: NM_000142.5(FGFR3):c.2173A>G (p.Met725Val) ()
🧬 FGFR3: NM_000142.5(FGFR3):c.380-1G>A ()
🧬 FGFR3: GRCh38/hg38 4p16.3(chr4:49556-3910769)x1 ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 62 variantes classificadas pelo ClinVar.

20
39
3
Patogênica (32.3%)
VUS (62.9%)
Benigna (4.8%)
VARIANTES MAIS SIGNIFICATIVAS
FGFR3: NM_000142.5(FGFR3):c.1075+95C>G [Conflicting classifications of pathogenicity]
FGFR3: NM_000142.5(FGFR3):c.1031C>G (p.Ser344Cys) [Pathogenic/Likely pathogenic]
FGFR3: NM_000142.5(FGFR3):c.1827C>G (p.Ala609=) [Conflicting classifications of pathogenicity]
FGFR3: NM_000142.5(FGFR3):c.473G>A (p.Arg158Gln) [Conflicting classifications of pathogenicity]
FGFR3: NM_000142.5(FGFR3):c.1183C>A (p.Leu395Ile) [Likely pathogenic]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
Aprovado1
3Fase 34
2Fase 211
·Pré-clínico6
Medicamentos catalogadosEnsaios clínicos· 2 medicamentos · 20 ensaios
✓ Aprovados — podem ser usados hoje
VOSORITIDE
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Acondroplasia

Centros de Referência SUS

24 centros habilitados pelo SUS para Acondroplasia

Centros para Acondroplasia

Detalhes dos centros

Hospital Universitário Prof. Edgard Santos (HUPES)

R. Dr. Augusto Viana, s/n - Canela, Salvador - BA, 40110-060 · CNES 0003808

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital Infantil Albert Sabin

R. Tertuliano Sales, 544 - Vila União, Fortaleza - CE, 60410-794 · CNES 2407876

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Apoio de Brasília (HAB)

AENW 3 Lote A Setor Noroeste - Plano Piloto, Brasília - DF, 70684-831 · CNES 0010456

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Estadual Infantil e Maternidade Alzir Bernardino Alves (HIABA)

Av. Min. Salgado Filho, 918 - Soteco, Vila Velha - ES, 29106-010 · CNES 6631207

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da UFG

Rua 235 QD. 68 Lote Área, Nº 285, s/nº - Setor Leste Universitário, Goiânia - GO, 74605-050 · CNES 2338424

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital Universitário da UFJF

R. Catulo Breviglieri, Bairro - s/n - Santa Catarina, Juiz de Fora - MG, 36036-110 · CNES 2297442

Atenção Especializada

Rota
Anomalias Congênitas

Hospital das Clínicas da UFMG

Av. Prof. Alfredo Balena, 110 - Santa Efigênia, Belo Horizonte - MG, 30130-100 · CNES 2280167

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Julio Müller (HUJM)

R. Luis Philippe Pereira Leite, s/n - Alvorada, Cuiabá - MT, 78048-902 · CNES 2726092

Atenção Especializada

Rota
Anomalias Congênitas

Hospital Universitário João de Barros Barreto

R. dos Mundurucus, 4487 - Guamá, Belém - PA, 66073-000 · CNES 2337878

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Lauro Wanderley (HULW)

R. Tabeliao Estanislau Eloy, 585 - Castelo Branco, João Pessoa - PB, 58050-585 · CNES 0002470

Atenção Especializada

Rota
Anomalias Congênitas

Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)

R. dos Coelhos, 300 - Boa Vista, Recife - PE, 50070-902 · CNES 0000647

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Pequeno Príncipe

R. Des. Motta, 1070 - Água Verde, Curitiba - PR, 80250-060 · CNES 3143805

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital Universitário Regional de Maringá (HUM)

Av. Mandacaru, 1590 - Parque das Laranjeiras, Maringá - PR, 87083-240 · CNES 2216108

Atenção Especializada

Rota
Anomalias Congênitas

Hospital de Clínicas da UFPR

R. Gen. Carneiro, 181 - Alto da Glória, Curitiba - PR, 80060-900 · CNES 2364980

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Pedro Ernesto (HUPE-UERJ)

Blvd. 28 de Setembro, 77 - Vila Isabel, Rio de Janeiro - RJ, 20551-030 · CNES 2280221

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (IFF/Fiocruz)

Av. Rui Barbosa, 716 - Flamengo, Rio de Janeiro - RJ, 22250-020 · CNES 2269988

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital São Lucas da PUCRS

Av. Ipiranga, 6690 - Jardim Botânico, Porto Alegre - RS, 90610-000 · CNES 2232928

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital de Clínicas de Porto Alegre (HCPA)

Rua Ramiro Barcelos, 2350 Bloco A - Av. Protásio Alves, 211 - Bloco B e C - Santa Cecília, Porto Alegre - RS, 90035-903 · CNES 2237601

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário da UFSC (HU-UFSC)

R. Profa. Maria Flora Pausewang - Trindade, Florianópolis - SC, 88036-800 · CNES 2560356

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital das Clínicas da FMUSP

R. Dr. Ovídio Pires de Campos, 225 - Cerqueira César, São Paulo - SP, 05403-010 · CNES 2077485

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Base de São José do Rio Preto

Av. Brg. Faria Lima, 5544 - Vila Sao Jose, São José do Rio Preto - SP, 15090-000 · CNES 2079798

Atenção Especializada

Rota
Anomalias Congênitas

Hospital de Clínicas da UNICAMP

R. Vital Brasil, 251 - Cidade Universitária, Campinas - SP, 13083-888 · CNES 2748223

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Ribeirão Preto (HCRP-USP)

R. Ten. Catão Roxo, 3900 - Vila Monte Alegre, Ribeirão Preto - SP, 14015-010 · CNES 2082187

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

UNIFESP / Hospital São Paulo

R. Napoleão de Barros, 715 - Vila Clementino, São Paulo - SP, 04024-002 · CNES 2688689

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo
Sobre os centros SUS: Estes centros são habilitados pelo Ministério da Saúde como Serviços de Referência em Doenças Raras ou Serviços de Atenção Especializada. O atendimento é pelo SUS, com encaminhamento da rede de atenção básica.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

12 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

47 ensaios clínicos encontrados, 19 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

🥉Melhor nível de evidência: Relato de caso
Timeline de publicações
915 papers (10 anos)

Mostrando amostra de 200 publicações de um total de 915

#1

Maternal decision-making through temporal uncertainties: The anticipatory biopolitics of Vosoritide in dwarfism communities.

Social science &amp; medicine (1982)2026 May

Vosoritide, a biotechnological therapy designed to increase growth in children with achondroplasia, has introduced new pressures and bodily possibilities for families navigating this rare genetic condition. While debates around its use often centre on its efficacy as a non-surgical growth treatment for the most common form of non-lethal human dwarfism, far less attention has been paid to how the medication (re)shapes the temporal landscape of maternal decision-making, children's bodily autonomy, and community dynamics. Drawing on qualitative interviews with mothers from UK dwarfism communities, comprising both average-statured and dwarf mothers, this research locates maternal decision-making within broader regimes of health governance, biosocial communities, and concepts of 'good' mothering. Conceptually, the article foregrounds how Vosoritide functions as a future-oriented health technology and a site of anticipatory biopolitics; governing decision-making through overlapping and complex regimes of temporality, maternal responsibilisation, and biosociality. Vosoritide emerges not only as a site of biomedical possibility, but also as a biopolitical discourse, shaping how mothers of children with dwarfism (re)imagine and manage their child's body, future, and identity. In doing so, this research advances sociological scholarship by exposing the temporal and anticipatory 'logics' through which biopower operates in the governance of dwarfism.

#2

METTL16 Modulates GPX4 Expression to Regulate Chondrocyte Ferroptosis.

Frontiers in bioscience (Landmark edition)2026 Feb 03

Achondroplasia (ACH), the predominant inherited form of disproportionate short stature, results from specific genetic alterations in fibroblast growth factor receptor 3 (FGFR3). N6-methyladenosine (m6A) modification is reported to modulate mRNA stability and translation. The present investigation systematically explored the epigenetic regulatory function of METTL16, an m6A RNA methyltransferase, within the pathophysiological framework of ACH. We generated an ACH mouse model via Fgfr3380R (Fgfr3ach) gene mutation. Primary chondrocytes were isolated from newborn mice and stimulated with IL-1β to induce cell death. Proximal tibia tissues were collected and analyzed with HE staining, toluidine blue staining, safranin O staining, and immunohistochemical (IHC) analysis. Bone structure was analyzed by measuring bone mineral density (BMD), ratio of bone volume to total tissue volume (BV/TV), trabecular number (TbN), and trabecular thickness (TbTh). Cell viability and proliferation were assessed using the Cell Counting Kit-8 (CCK-8) and colony formation assays. The levels of iron (Fe2+), malondialdehyde (MDA), and glutathione (GSH) were measured to assess ferroptosis. Protein and RNA levels were measured by western blotting and quantitative real-time PCR (qPCR) assay, respectively, while the m6A modification level was assessed by m6A mRNA immunoprecipitation (IP). METTL16 improved bone chondrogenesis in the ACH mouse model, with METTL16 overexpression promoting the proliferation of primary chondrocytes. METTL16 decreased ferroptosis both in vitro and in vivo and increased glutathione peroxidase 4 (GPX4) expression. METTL16 enhanced m6A modification of GPX4 mRNA and suppressed its degradation. Depletion of GPX4 abolished the effects of METTL16 on ACH mice and chondrocytes. Overexpression of METTL16 improved bone growth and alleviated ferroptosis of chondrocytes by increasing m6A modification of GPX4 mRNA and thus GPX4 expression in chondrocytes. The METTL16/GPX4 axis may be a promising therapeutic approach for ACH treatment.

#3

Excess FGFR3 signaling in achondroplasia disrupts turnover of resting zone chondrocytes via CREB signaling.

Nature communications2026 Feb 26

Achondroplasia, associated with gain-of-function mutations in FGFR3, causes growth plate cartilage dysfunction, resulting in short-limb dwarfism. However, its precise molecular and cellular mechanisms remain unclear. To address this, we aimed to generate knock-in mice (Fgfr3Ach) harboring the achondroplasia mutation (p.Gly380Arg). In addition to previously reported abnormalities, we observe an expansion of the resting zone. EdU labeling and lineage tracing analyses indicate that disruption of turnover and impairment of stem cell-like behavior of resting zone chondrocytes results in accumulation of cells in the resting zone. Single-cell RNA-seq and immunohistochemical analysis identify a cell cluster that corresponds to the expanded resting zone. Pathway analysis and functional experiments reveal that CREB disrupts stem cell-like properties in resting zone chondrocytes and contributes to dwarfism. Administration of CREB inhibitor 666-15 restores growth plate pathology and bone length. These findings demonstrate that excess FGFR3 signaling disrupts resting zone chondrocyte properties and suggest potential therapeutic targets for achondroplasia.

#4

Foramen magnum stenosis, cervicomedullary decompression, and growth in children with achondroplasia: a retrospective cohort study.

Orphanet journal of rare diseases2026 Jan 29

Foramen magnum stenosis (FMS) is a serious complication in children with achondroplasia that may necessitate cervicomedullary decompression (CMD). It is unclear how FMS and CMD influence growth in these children. This study aimed to assess the effects of FMS and CMD on the growth of children with achondroplasia. Eighty-seven children (45 males, 42 females) with achondroplasia, aged 4 to 6 years, were evaluated. Height, weight, head circumference, and body mass index were expressed as standard deviation scores (SDS) according to Merker et al., while sitting height SDS was derived using Tanner’s methods. FMS was graded on magnetic resonance imaging using Fornarino’s score. Fifty-two patients (26 males, 26 females) underwent CMD at a median age of 0.95 years (IQR 0.52;1.50). Of these, 28 (53.8%) were under one year old at the time of CMD, with a median age of 0.6 years (0.4;0.7). The remaining 24 children had CMD after their first year of life, with a median age of 1.6 years (1.3;2.8). The median age at anthropometric assessment was 5.16 years (4.74;5.50). Children who underwent CMD showed significantly lower median height SDS, particularly among males compared to females (p=0.026). Impaired growth in children with foramen magnum stenosis requiring cervicomedullary decompression may primarily reflect greater disease severity, while the potential contribution of surgery remains uncertain.

#5

Spatiotemporal Regulation and Lineage Specification in Embryonic Endochondral Ossification.

International journal of molecular sciences2026 Jan 16

Long bone formation in vertebrates proceeds via endochondral ossification, a sequential process that begins with mesenchymal condensation, advances through cartilage anlage formation, and culminates in its replacement by mineralized bone. Recent advances in inducible lineage tracing and single-cell genomics have revealed that, rather than being a uniform event, mesenchymal condensation rapidly segregates into progenitor pools with distinct fates. Centrally located Sox9+/Fgfr3+ chondroprogenitors expand into the growth plate and metaphyseal stroma, peripheral Hes1+ boundary cells refine condensation via asymmetric division, and outer-layer Dlx5+ perichondrial cells generate the bone collar and cortical bone. Concurrently, dorsoventral polarity established by Wnt7a-Lmx1b and En1 ensures that dorsal progenitors retain positional identity throughout development. These lineage divergences integrate with signaling networks, including the Ihh-PTHrP, FGF, BMPs, and WNT/β-catenin networks, which impose temporal control over chondrocyte proliferation, hypertrophy, and vascular invasion. Perturbations in these programs, exemplified by mutations in Fgfr3, Sox9, and Dlx5, underlie region-specific skeletal dysplasias, such as achondroplasia, campomelic dysplasia, and split-hand/foot malformation, demonstrating the lasting impacts of embryonic patterning errors. Based on these insights, regenerative strategies are increasingly drawing upon developmental principles, with organoid cultures recapitulating ossification centers, biomimetic hydrogels engineered for spatiotemporal morphogen delivery, and stem cell- or exosome-based therapies harnessing developmental microRNA networks. By bridging developmental biology with biomaterials science, these approaches provide both a roadmap to unravel skeletal disorders and a blueprint for next-generation therapies to reconstruct functional bones with the precision of the embryonic blueprint.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC1.467 artigos no totalmostrando 198

2026

The Clinical Utility of Whole-Exome Sequencing in the Prenatal Diagnosis of Fetal Skeletal Dysplasia.

International journal of women's health
2026

Efficacy and safety of limb lengthening in achondroplasia: A systematic review and meta-analysis.

International orthopaedics
2026

Analysis of fetal MRI data reveals no effect on liver maturation following prenatal alcohol exposure.

European radiology
2026

Factors Associated with Inconveniences in Daily At-home Living among Adults with Achondroplasia.

Progress in rehabilitation medicine
2026

Early Neonatal Administration of Vosoritide in Achondroplasia: A Report of Two Cases.

American journal of medical genetics. Part A
2026

Genotype-phenotype correlations in PSACH/EDM1 patients with COMP gene variants: a comprehensive review of 830 cases.

Frontiers in endocrinology
2026

Effect of vosoritide on spine morphology in children with achondroplasia: 1-year results from a randomized phase 2 study.

Journal of the Endocrine Society
2026

Economic Burden and Health-Related Quality of Life Among Children With Achondroplasia in China: A Cross-Sectional Study.

Value in health regional issues
2026

Effect of vosoritide on genu varum in children with achondroplasia after 1 year in randomized placebo-controlled trials.

Journal of the Endocrine Society
2026

Development of Muscle Function in Children with Achondroplasia Under Vosoritide Treatment: A Retrospective Single-Centre Observational Study.

Journal of musculoskeletal &amp; neuronal interactions
2026

Maternal decision-making through temporal uncertainties: The anticipatory biopolitics of Vosoritide in dwarfism communities.

Social science &amp; medicine (1982)
2026

Pathways to Facilitate Early Recognition and Diagnosis of Hypochondroplasia.

Advances in therapy
2026

METTL16 Modulates GPX4 Expression to Regulate Chondrocyte Ferroptosis.

Frontiers in bioscience (Landmark edition)
2026

Excess FGFR3 signaling in achondroplasia disrupts turnover of resting zone chondrocytes via CREB signaling.

Nature communications
2026

Corrigendum to "Bipedal static postural stability in children with achondroplasia compared to typically developed children in the age range of 9-12 years - A pilot study" [Gait Posture 117 (2025) 337-341].

Gait &amp; posture
2026

T1-T12 and T1-S1 Lengths at Maturity in Patients With Skeletal Dysplasia.

Journal of pediatric orthopedics
2026

Foramen Magnum Stenosis in Achondroplasia: Imaging-Based Surgical Indications, Synchondrosis Fusion, and the Role of Ventriculomegaly.

Pediatric neurosurgery
2025

Clarification regarding surgical comparisons in achondroplasia and OSA.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
2026

Practical guidance for clinicians to optimise orthopaedic outcomes in achondroplasia: International Achondroplasia Forum guiding principles.

Bone
2026

The Metacarpophalangeal Pattern Profile: An Old Method With New Insights Into the Evaluation of Short Stature.

American journal of human biology : the official journal of the Human Biology Council
2026

[Key points of the International consensus guidelines on the implementation and monitoring of vosoritide therapy in individuals with Achondroplasia].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2026

The CrescNet Registry Achondroplasia Module: Real-World Demographic Data and Clinical Outcomes in Untreated and Vosoritide-Treated Individuals.

Hormone research in paediatrics
2026

Foramen magnum stenosis, cervicomedullary decompression, and growth in children with achondroplasia: a retrospective cohort study.

Orphanet journal of rare diseases
2026

Multilevel Laminectomy for Lumbar Spinal Stenosis With Low Back Pain in Achondroplasia: A Case Report.

The American journal of case reports
2026

Spatiotemporal Regulation and Lineage Specification in Embryonic Endochondral Ossification.

International journal of molecular sciences
2026

Infigratinib is a weak inhibitor of the FGFR3-N540K mutant associated with hypochondroplasia.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
2025

The anterior cervical approach in pediatric patients: indications and outcomes.

Journal of neurosurgery. Pediatrics
2026

UK consensus guidelines for multidisciplinary care of children and young people with achondroplasia: a modified Delphi process.

Archives of disease in childhood
2026

An overview of the International Consensus Statement on achondroplasia.

Orphanet journal of rare diseases
2026

Homozygous Achondroplasia With Long-Term Survival: Growth Patterns, Medical Interventions, and Practice Implications.

American journal of medical genetics. Part A
2025

Otologic Axis and Sleep-Disordered Breathing in Achondroplasia: Age-Structured Cohort Findings.

Healthcare (Basel, Switzerland)
2026

Functional analysis of NPR2 variants supports the therapeutic rationale for CNP in short stature.

American journal of human genetics
2025

Pregnancy and Delivery in a Woman With Achondroplasia: A Multidisciplinary Management Approach.

Cureus
2026

Longitudinal Observation of Children with Achondroplasia: Findings from a Global Natural History Study (ACHieve).

Hormone research in paediatrics
2025

Elevated MMP9 Expression-A Potential In Vitro Biomarker for COMPopathies.

International journal of molecular sciences
2026

Real-world outcomes of vosoritide in achondroplasia: A systematic review and meta-analysis of multinational clinical evidence.

Genetics in medicine : official journal of the American College of Medical Genetics
2026

C-type natriuretic peptide as mediator of growth in the absence of growth hormone: Unraveling the mystery of the growth without GH syndrome.

Hormones (Athens, Greece)
2025

Detection of fetal structural abnormalities at 20 and 30 weeks: a retrospective study of prenatal ultrasound screening.

Journal of medical ultrasonics (2001)
2025

Posterior decompression and spinous process reconstruction for lumbar spinal stenosis in a pediatric patient with achondroplasia: a case report.

Journal of medical case reports
2025

Three-dimensional craniofacial imaging in children with achondroplasia treated with vosoritide.

Genetics in medicine open
2026

Generalized Epidermal Nevus and Acanthosis Nigricans Due to a Postzygotic FGFR3 Variant.

JAMA dermatology
2025

Efficacy and Safety of Oral Meclizine for Growth Promotion in Children with Achondroplasia: A Phase 2 Clinical Trial.

Calcified tissue international
2026

Qualitative Research in Children and Parents of Children with Achondroplasia to Evaluate the Content Validity of Multiple Clinical Outcome Assessments.

Advances in therapy
2025

Spinal Stenosis in Achondroplasia - A Case Report and Review of the Literature.

Journal of orthopaedic case reports
2026

Frame matters: Rethinking prone positioning for spinal surgery in achondroplasia.

Journal of perioperative practice
2026

Once-Weekly Navepegritide in Children With Achondroplasia: The APPROACH Randomized Clinical Trial.

JAMA pediatrics
2026

The gut microbiota-derived metabolites regulate bone extracellular matrix homeostasis: Mechanisms and therapeutic implications.

Cellular signalling
2026

Functional Change in Three Adolescents With Achondroplasia Following 12 Months Treatment With Vosoritide-A Case Series.

Journal of paediatrics and child health
2026

Real-world safety and age-dependent effectiveness of vosoritide in achondroplasia: A single-center retrospective analysis of transition from growth hormone to vosoritide.

Bone
2025

Crouzonodermoskeletal syndrome requires individualized surgical management: Scoping review of a rare complex craniofacial syndrome.

JPRAS open
2025

Young Adults With Achondroplasia, Self-Esteem, and Wellbeing: Examining the Impact of Dance Sessions and Augmented Dance Sessions.

Creative nursing
2026

Feeding, Nutrition, and Physical Activity From the Perspectives of People With Skeletal Dysplasia in Australia and Norway: A Mixed Qualitative Methods Study.

American journal of medical genetics. Part A
2025

Clinical burden and healthcare resource utilization associated with achondroplasia: a real-world observational, retrospective cohort study.

Orphanet journal of rare diseases
2026

CORR Insights®: Are the Clinical Outcomes of Lumbar Stenosis in Achondroplasia Associated With the Severity of Stenosis and Sagittal Balance?

Clinical orthopaedics and related research
2025

Achondroplasia and hypochondroplasia in France: a nationwide epidemiological analysis.

Orphanet journal of rare diseases
2025

A Natural Part of Human Diversity.

Creative nursing
2025

Anesthetic management of children undergoing specialized orthopedic surgeries.

Journal of clinical orthopaedics and trauma
2026

Cardiovascular risk in achondroplasia: a systematic review.

Journal of medical genetics
2025

From Protein Misfolding to Extracellular Matrix Disorganisation: Understanding Disease Pathology in Rare Skeletal Dysplasias.

International journal of molecular sciences
2025

Achondroplasia treatments in children aged 5 and older.

Molecular and cellular pediatrics
2025

Simultaneous bilateral total knee replacement in a patient with achondroplasia and severe varus deformity: a case report.

Journal of surgical case reports
2025

Surgical and anaesthesia decision making algorithms in patients with congenital spinal stenosis: a case report of awake endoscopic decompression in a patient with achondroplasia and literature review.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society
2025

[Clinical features and variant spectrum of FGFR3-related disorders].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
2025

Body composition, anthropometry, and resting energy expenditure in adults with achondroplasia: a pilot study to determine best practices.

Orphanet journal of rare diseases
2025

FGFR3 gain-of-function delays intramembranous bone healing in a mouse calvarial fracture model.

Biochemical and biophysical research communications
2025

Quantitative Gait Assessment before and after Limb Lengthening in a Patient with Achondroplasia: A Case Report.

Progress in rehabilitation medicine
2025

Functional Independence Assessment in Children and Adolescents with Achondroplasia: A Multicenter Cross-Sectional Study Using the WeeFIM Scale.

Diagnostics (Basel, Switzerland)
2025

Constitutive activation of activin receptor-like kinase 3 in chondrocytes exacerbates skeletal dysplasia in mice with achondroplasia.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
2025

Thanatophoric Dysplasia Type 1 Treated with Vosoritide: A Case Report.

Hormone research in paediatrics
2025

External hinge fixation system for leg lengthening and correction of axial deviations, / Salamehfix 1/. configuration and clinical advantages.

International orthopaedics
2026

Exome Sequencing Reveals Novel Variants in Genetic Skeletal Disorders: Insights From a Cohort in Southwest Iran.

Clinical genetics
2026

Basal Metabolic Requirements, Biomarkers of Cardiometabolic Health, and Anthropometric Measures of Obesity in Women and Men With Restricted Growth Conditions.

American journal of medical genetics. Part A
2026

Are the Clinical Outcomes of Lumbar Stenosis in Achondroplasia Associated With the Severity of Stenosis and Sagittal Balance?

Clinical orthopaedics and related research
2025

Challenges and solutions in the treatment of spinal disorders in patients with skeletal dysplasia: A comprehensive review.

World journal of methodology
2026

Comparative Outcomes of 8.5 mm Intramedullary Nails Versus Extramedullary Constructs for Femoral Lengthening in Pediatric Patients.

Journal of pediatric orthopedics
2025

Postoperative Rehabilitation Following Total Hip Arthroplasty in Achondroplasia: A Case Report Focused on Dislocation Prevention and Environmental Simulation.

Cureus
2025

Assessing the clinical relevance of MRI findings in adult achondroplasia patients with lumbar spinal stenosis.

Brain &amp; spine
2025

Vosoritide (Voxzogo) for Achondroplasia: A Review of Clinical and Real-World Evidence.

Cureus
2025

The Value of Enhancing Sonographic Phenotyping to Improve the Diagnostic Yield of Noninvasive Prenatal Diagnosis (NIPD) for Achondroplasia.

Prenatal diagnosis
2025

Mitral Valve Repair in a Patient With Achondroplasia.

JACC. Case reports
2025

Development of the QoLISSY 0-4 questionnaire: a health-related quality of life tool for young children with short stature.

Journal of patient-reported outcomes
2026

Prone positioning for spinal surgery in achondroplasia: A case study report.

Journal of perioperative practice
2025

Anaesthesia for infants and young children with achondroplasia.

BJA education
2025

Duplicated superior vena cava in a patient with tetralogy of Fallot: A rare vascular anomaly.

Radiology case reports
2025

An AI-assisted tool for automated growth monitoring in pediatric achondroplasia.

European journal of pediatrics
2025

Integrating vosoritide therapy with limb surgery in paediatric patients with achondroplasia: real-life experiences.

Orphanet journal of rare diseases
2025

Sleep-disordered breathing in children with achondroplasia assessed by polysomnography: a retrospective chart review.

Archives of disease in childhood
2025

Discovery of Potent FGFR2/3 Inhibitors to Overcome Mutation Resistance and Treat Achondroplasia.

ACS medicinal chemistry letters
2025

Prevalence of low birth weight, short length, and body disproportion at birth in patients with skeletal dysplasias: A retrospective study.

Archivos argentinos de pediatria
2025

Genetics of short stature.

Current opinion in pediatrics
2025

[Skeletal dysplasias-Multidisciplinary orthopedics].

Orthopadie (Heidelberg, Germany)
2025

Neurologic outcomes in patients with skeletal dysplasias undergoing cervical fusion and occipitocervical fusion.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2025

Resolving the design principles that control post-natal vascular growth and scaling.

Cell systems
2025

Enhancing care coordination for neurofibromatosis type 1 in primary care: insights and applications for rare diseases.

Journal of community genetics
2025

Signatures of selection detected from whole-genome sequencing indicate that the small body size in dwarf rabbit breeds is caused by polygenic effects with a few major loci.

Animal genetics
2025

Infigratinib low dose therapy is an effective strategy to treat hypochondroplasia.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
2025

C-type natriuretic peptide and collagen X marker are aberrant in skeletal dysplasias.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
2025

A Single-Center Retrospective Analysis of a Standardized Sedation Protocol for MRI in Children with Achondroplasia: Minimal Complications and Excellent Imaging Quality.

Children (Basel, Switzerland)
2025

Sleep apnea in patients with achondroplasia associated with foramen magnum stenosis.

Journal of neurosurgery. Pediatrics
2025

Oral Infigratinib Therapy in Children with Achondroplasia. Reply.

The New England journal of medicine
2025

Oral Infigratinib Therapy in Children with Achondroplasia.

The New England journal of medicine
2025

Differences in gait parameters between children with achondroplasia and an age-matched control group of typically developed children in the age range of 6 to 12 years.

PloS one
2025

Rehabilitation in a child with Chiari II malformation, lumbosacral meningomyelocele, achondroplasia and impaired respiratory regulation - a case report and literature review.

Journal of pediatric rehabilitation medicine
2025

Coping and quality of life of parents of children with achondroplasia-a narrative review.

Frontiers in medicine
2025

[An update review of advances in the treatment of achondroplasia].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2025

Health State Utilities for Achondroplasia: A Time Trade-Off Study.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
2025

Real-World Safety and Effectiveness of Vosoritide in Achondroplasia: Results from a Single Center in Portugal.

Advances in therapy
2025

Development of an individualized and functional CPAP ventilation mask using a fully digital workflow by facial scanning and additive manufacturing for a child with craniofacial anomalies.

Sleep medicine
2025

Dynamic MRI in the Evaluation of the Cervical Spine in Pediatric Patients With Achondroplasia.

American journal of medical genetics. Part A
2025

Potential efficacy of vosoritide for foramen magnum stenosis in a patient with achondroplasia.

Pediatrics international : official journal of the Japan Pediatric Society
2025

Phosphodiesterase 3 inhibitors boost bone outgrowth.

British journal of pharmacology
2025

Survivorship of Individuals With Double Heterozygosity for Achondroplasia and Type 2 Collagenopathy.

American journal of medical genetics. Part A
2025

An infant with achondroplasia worsening of the foramen magnum stenosis during early vosoritide treatment.

Pediatrics international : official journal of the Japan Pediatric Society
2025

Technical performance analyses in elite Paralympic swimming using wearable technology: two case studies.

Sports biomechanics
2025

Mechanisms associated with obstructive sleep apnea in achondroplasia.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
2025

[Clinical analysis in 15 pediatric patients with osteochondrodysplasias related to COMP gene variants].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2025

Management of sleep-disordered breathing in achondroplasia: guiding principles of the European Achondroplasia Forum.

Orphanet journal of rare diseases
2025

TACC3 facilitates chondrocyte differentiation by attenuating abnormally activated FGFR3 signaling in achondroplasia - An in vitro study.

Tissue &amp; cell
2025

Gait Improvement After Distal Femoral Osteotomy for Permanent Patellar Dislocation Following Femoral Lengthening in an Adolescent With Achondroplasia: A Case Report.

Cureus
2025

Transition Care for Young Persons with Rare Bone Mineral Conditions: A Consensus Recommendation from the ECTS Rare Bone Disease Action Group.

Calcified tissue international
2025

Ensuring diverse representation and minimizing conflicts of interest in clinical practice guidelines.

Nature reviews. Endocrinology
2025

Comparison of bilateral tibial lengthening with circular external fixator and simultaneous deformity correction with hexapod external fixator in Achondroplasia.

European journal of medical genetics
2025

Balancing independence: Priorities, tensions, obstacles, and facilitators for independence among young adults with skeletal dysplasia and short stature.

Journal of genetic counseling
2025

Hypertrichosis associated with the use of C-type natriuretic peptide analogue: a case report.

Journal of medical case reports
2025

Radiofrequency Probe Guidance in Peripheral Nerve Stimulator Placement for Complex Anatomy: A Case Report.

Pain medicine case reports
2025

Advances in the mechanism and therapies of achondroplasia.

Genes &amp; diseases
2025

Genetic variations in pseudoachondroplasia: a review of case reports.

Laboratory medicine
2025

Changes in the Alignment of the Spine and Lower Limb in Children With Achondroplasia Treated With Vosoritide: A Single-center, 1-year Follow-up Prospective Study.

Journal of pediatric orthopedics
2025

New Argentine head circumference references for people with achondroplasia from 0 to 21 years of age.

Archivos argentinos de pediatria
2025

TYRA-300, an FGFR3-selective inhibitor, promotes bone growth in two FGFR3-driven models of chondrodysplasia.

JCI insight
2025

Unilateral biportal endoscopic decompression for lumbar spinal stenosis in achondroplasia: a 30-month follow up case report.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society
2025

The Awake Resting Breathing and Thoraco-Abdominal Pattern In Children With Achondroplasia: A Pilot Cross-Sectional Study.

Health science reports
2025

Biomechanical Evaluation and Analysis of a Reused Telescopic Intramedullary Femoral Nail in a Child with Achondroplasia.

Revista espanola de cirugia ortopedica y traumatologia
2025

Health-Related Quality of Life of Individuals with Physical Disabilities in Childhood.

Children (Basel, Switzerland)
2025

Real-world Outcome of Vosoritide Treatment in Children With Achondroplasia: A 12-month Retrospective Observational Study.

Journal of the Endocrine Society
2025

Routine 36-week scan: diagnosis of fetal abnormalities.

Ultrasound in obstetrics &amp; gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
2025

Bilateral Total Hip Arthroplasty in a Patient With Achondroplasia: Challenges and Surgical Strategies.

Arthroplasty today
2025

[Significance and considerations of early diagnosis and treatment for improving height outcomes in children with achondroplasia].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
2025

Limb lengthening in individuals with achondroplasia: Analysis of an international survey.

Bone
2025

Functional Change in a Child With Achondroplasia Following 12 Months Treatment With Vosoritide-A Case Report.

American journal of medical genetics. Part A
2025

Immediate Autologous Breast Reconstruction in a Patient With Achondroplasia.

Annals of plastic surgery
2025

Mental health conditions, physical functioning, and health-related quality of life in adults with a skeletal dysplasia: a cross-sectional multinational study.

Orphanet journal of rare diseases
2025

Recommendations for management of infants and young children with achondroplasia: Does clinical practice align?

Orphanet journal of rare diseases
2025

Clinical and economic burden of achondroplasia in the United States: results from a retrospective, observational study.

Orphanet journal of rare diseases
2025

Oral Infigratinib in Children with Achondroplasia - Targeted Treatment.

The New England journal of medicine
2025

Multidisciplinary Management of Acute Tetraparesis in an Infant with Achondroplasia, with a Focus on Anesthetic Strategies: A Case Report.

Children (Basel, Switzerland)
2025

Flexion-extension cervical MRI imaging in pediatric patients with achondroplasia unsupervised by neurosurgery or radiology, is it safe?

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2025

Functional performance and symptomatology of adults with skeletal dysplasia across self-care, mobility, and cognition-a cross-sectional study.

JBMR plus
2025

Characteristics of sleep disordered breathing in children with achondroplasia.

Sleep &amp; breathing = Schlaf &amp; Atmung
2025

Management of Maternal Genetic Conditions in Pregnancy, Part 1: Disorders of the Connective Tissue, Muscle, Vascular, and Skeletal Systems.

Obstetrical &amp; gynecological survey
2025

Achondroplasia and obstructive sleep apnea: surgical outcomes and comparison to general population.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
2025

Considerations for Anthropometry Specific to People with Disproportionate Short Stature.

Advances in therapy
2025

Anesthetic Management of Parturients With Achondroplasia During Labor and Delivery: A Narrative Review.

Anesthesia and analgesia
2025

Early evaluation and treatment of thoracolumbar kyphosis in children with achondroplasia.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society
2025

Achondroplasia Status and Adverse Short-Term Postoperative Outcomes in Elective Spinal Decompression Surgery: A Propensity Score-Matched Case-Control Study.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
2025

RMRP variants inhibit the cell cycle checkpoints pathway in cartilage‑hair hypoplasia.

Molecular medicine reports
2025

Prevalence and natural development of thoracolumbar kyphosis in achondroplasia: A systematic review and meta-analysis.

Brain &amp; spine
2025

Real-World Safety and Effectiveness of Vosoritide in Children with Achondroplasia: French Early Access Program.

Hormone research in paediatrics
2025

Frontal Plane Knee Kinematics and Kinetics During Gait in Children and Youth with Achondroplasia-Correspondence with Static X-Ray Images and Relevance to Symptoms.

Children (Basel, Switzerland)
2025

[Lenthening and reconstruction progress of achondroplastic short arm deformity].

Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
2025

Evolution of sleep disordered breathing in infants with achondroplasia.

Sleep &amp; breathing = Schlaf &amp; Atmung
2025

Bipedal static postural stability in children with achondroplasia compared to typically developed children in the age range of 9-12 years - A pilot study.

Gait &amp; posture
2025

Impact of lower limb lengthening with telescopic nails on functionality and quality of life in patients with achondroplasia.

Revista espanola de cirugia ortopedica y traumatologia
2025

Fgfr3 enhancer deletion markedly improves all skeletal features in a mouse model of achondroplasia.

The Journal of clinical investigation
2025

Approach to the Patient with Achondroplasia-New Considerations for Diagnosis, Management, and Treatment.

The Journal of clinical endocrinology and metabolism
2024

Loss of CHOP Prevents Joint Degeneration and Pain in a Mouse Model of Pseudoachondroplasia.

International journal of molecular sciences
2025

International consensus guidelines on the implementation and monitoring of vosoritide therapy in individuals with achondroplasia.

Nature reviews. Endocrinology
2025

A homozygous variant in FGFR3 causing lethal skeletal dysplasia.

Sudanese journal of paediatrics
2025

New directions in growth hormone treatment in children.

Pediatric endocrinology, diabetes, and metabolism
2025

Sustained growth-promoting effects of vosoritide in children with achondroplasia from an ongoing phase 3 extension study.

Med (New York, N.Y.)
2024

Management of Methicillin-Resistant Staphylococcus aureus-infected femoral nonunion during lengthening in achondroplasia using circular external fixator: a case report.

BMC musculoskeletal disorders
2024

Resolving the design principles that control postnatal vascular growth and scaling.

bioRxiv : the preprint server for biology
2024

Prevalence and Associated Factors of Ankle Osteoarthritis in Achondroplasia: A Retrospective Radiographic Assessment of 134 Patients.

Cartilage
2024

Prenatal diagnosis of achondroplasia and hypochondroplasia using three-dimensional computed tomography: a case series at a single institution.

Quantitative imaging in medicine and surgery
2025

Anesthetic management of pregnant women with skeletal dysplasia and short stature: a case report.

Revista espanola de anestesiologia y reanimacion
2025

CDK8 inhibitor KY-065 rescues skeletal abnormalities in achondroplasia model mice.

Biochimica et biophysica acta. Molecular basis of disease
2024

Lifetime Impact Study for Achondroplasia (LISA): Findings from an observational and multinational study focused on health-related quality of life in individuals with achondroplasia in Latin America.

Genetics in medicine open
2025

Intrauterine blood transfusion causes dose- and time-dependent signal alterations in the liver and the spleen on fetal magnetic resonance imaging.

European radiology
2024

Otologic Manifestations in Patients with Achondroplasia: A Multicenter Study.

The journal of international advanced otology
2024

Prenatal diagnosis of achondroplasia in primary care settings - Recognising the soft markers: A case report.

Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia
2024

Expert consensus for the management of patients with achondroplasia in treatment with vosoritide.

Anales de pediatria
2025

Foetal achondroplasia: Prenatal diagnosis, outcome and perspectives.

Journal of gynecology obstetrics and human reproduction
2024

Syndrome-informed phenotyping identifies a polygenic background for achondroplasia-like facial variation in the general population.

Nature communications
2024

Pseudoachondroplasia associated with os odontoideum and retro-odontoid mass: case-based update.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2024

Feasibility study of the psychosocial effects of an online mindfulness intervention in children and adolescents with achondroplasia and their parents.

European journal of medical genetics
2024

Anatomical Characteristics of Cervicomedullary Compression on MRI Scans in Children with Achondroplasia.

Journal of imaging
2024

Myriad of congenital excavated optic disc anomalies in achondroplasia.

BMJ case reports
2025

Quality of Life in Short Stature Children With Skeletal Dysplasia: A Cross Sectional Study Using the Quality of Life in Short Stature Youth Questionnaire.

American journal of medical genetics. Part A
2024

[Achondroplasia : New era of orthopedic treatment?].

Orthopadie (Heidelberg, Germany)
2024

Intradural T12-L1 disc herniation in a patient with achondroplasia: A case report.

Surgical neurology international
2025

Meclozine and growth hormone ameliorate bone length and quality in experimental models of achondroplasia.

Journal of bone and mineral metabolism
2025

Challenges to self-care and domestic life for adults with disproportionate short statured skeletal dysplasia: a mixed method systematic review.

Disability and rehabilitation
2024

Retrospective evaluation of obstetric processes in patients with Familial Mediterranean Fever's disease: The three years experience of a tertiary rheumatology clinic.

Taiwanese journal of obstetrics &amp; gynecology
2026

Phase 2 Trial of Vosoritide Use in Patients with Hypochondroplasia: A Pharmacokinetic/Pharmacodynamic Analysis.

Hormone research in paediatrics
2024

Achondroplasia: aligning mouse model with human clinical studies shows crucial importance of immediate postnatal start of the therapy.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
2024

Assessment of the efficacy of vosoritide therapy in children with achondroplasia in clinical trials.

Translational pediatrics
2024

Vosoritide therapy in children with achondroplasia under 5 years of age.

Translational pediatrics
2024

Achondroplasia current concept of orthopaedic management.

Journal of children's orthopaedics
Ver todos os 1.467 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Associação brasileira dedicada a Acondroplasia.

Associação brasileira dedicada a Nanismo.

Associação brasileira dedicada a Acondroplasia.

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Acondroplasia

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Maternal decision-making through temporal uncertainties: The anticipatory biopolitics of Vosoritide in dwarfism communities.
    Social science &amp; medicine (1982)· 2026· PMID 41762856mais citado
  2. METTL16 Modulates GPX4 Expression to Regulate Chondrocyte Ferroptosis.
    Frontiers in bioscience (Landmark edition)· 2026· PMID 41761981mais citado
  3. Excess FGFR3 signaling in achondroplasia disrupts turnover of resting zone chondrocytes via CREB signaling.
    Nature communications· 2026· PMID 41748604mais citado
  4. Foramen magnum stenosis, cervicomedullary decompression, and growth in children with achondroplasia: a retrospective cohort study.
    Orphanet journal of rare diseases· 2026· PMID 41612394mais citado
  5. Spatiotemporal Regulation and Lineage Specification in Embryonic Endochondral Ossification.
    International journal of molecular sciences· 2026· PMID 41596573mais citado
  6. A Phase II Basket Trial of Vosoritide in Children with RASopathies, ACAN and NPR2 Deficiency.
    J Clin Endocrinol Metab· 2026· PMID 41967490recente
  7. Development of a Step-By-Step Clinical Decision Tool for Difficult Spinal Anesthetics: A Case Report of a Pregnant Patient With Achondroplasia, Previous Lumbar Fusion, and Class III Obesity.
    A A Pract· 2026· PMID 41955427recente
  8. Dkk1 inhibition restores mandibular growth in an achondroplasia mouse model.
    Biol Open· 2026· PMID 41954527recente
  9. Achondroplasia.
    · 1993· PMID 20301331recente
  10. Orthodontic and Maxillofacial Surgery Treatment in Achondroplasia for Orofacial Alterations: A Systematic Review and Preliminary Age-Stratified Guidelines.
    Orthod Craniofac Res· 2026· PMID 41937556recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:15(Orphanet)
  2. OMIM OMIM:100800(OMIM)
  3. MONDO:0007037(MONDO)
  4. GARD:8173(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Artigo Wikipedia(Wikipedia)
  8. Q340594(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Acondroplasia
Compêndio · Raras BR

Acondroplasia

ORPHA:15 · MONDO:0007037
🇧🇷 Brasil SUS
CEAF
1AVosoritida
Geral
Prevalência
Unknown
Herança
Autosomal dominant
CID-10
Q77.4 · Acondroplasia
CID-11
Ensaios
19 ativos
Medicamentos
2 registrados
Início
Antenatal, Neonatal
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C0001080
EuropePMC
Wikidata
Wikipedia
Papers 10a
Evidência
🥉 Relato de caso
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades